Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.
Caswell-Jin JL, Somerfield MR, Khan MA, Kimmick GG, Gupta S, Kenan K, Peswani N, Hershman DL, Ernst BJ, Harvey BE, Krings G, McAndrew NP, Riaz IB, Vaz-Luis I, Villarreal-Garza C, Oberoi JK, Sadiq MH, He H, Chitale R, Hassett MJ
Projected health benefits and cost offsets from the United States National Hepatitis C Elimination Initiative.
Chhatwal J, Aaron A, Zhong H, Sood N, Irvin R, Alter HJ, Zhuo Y, Sharfstein JM, Ward JW
Virtual Sustained Tobacco Treatment for Patients With Cancer: A Randomized Controlled Trial (ECOG-ACRIN: EAQ171CD) Within the National Cancer Institute Community Oncology Research Program.
Park ER, Sicks JD, Goshe BM, Gareen IF, Herman BA, Taurone A, Bittig S, Walter AW, Regan S, Rosen R, Durieux N, Rasmussen AW, Levy DE, Nicolosi G, Muzikansky A, Thompson MA, Lui M, Malloy L, Gonzalez I, Finkelstein-Fox L, Munson ND, Greenwade MM, King DM, Jenigiri B, Burnette BL, Throckmorton AD, Tingen MS, Carlos RC, Wagner LI, Ostroff JS
The Oncology Care Model and Medicare Payments, Utilization, and Quality.
Brooks GA, Trombley M, McClellan S, Zheng Q, Landrum MB, Hsu VD, Kummet CM, Liu PH, Hoodin D, Doyle C, Simon C, Keating NL
Extended Endocrine Therapy and Survival for Breast Cancer Subtypes in Premenopausal Patients.
Valenza C, Zheng Y, Milano M, Berton Giachetti PPM, Trapani D, Giordano E, Guidi L, Boldrini L, Castellano G, Katrini J, Malagutti B, Antonarelli G, Etessami JD, Bianco N, Conforti F, Kirkner GJ, Sangalli C, Dibble KE, Fusco N, Colleoni M, Regan MM, Munzone E, Curigliano G, Partridge AH
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial.
Pagani O, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Warner E, Amant F, Mailliez A, Moore HCF, Ruiz-Borrego M, Walshe JM, Borges VF, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Saunders C, Bjelic-Radisic V, Susnjar S, Cardoso F, Klar NJ, Ferreiro T, Ribi K, Ruddy KJ, Kammler R, El-Abed S, Viale G, Piccart M, Korde LA, Goldhirsch A, Gelber RD, Partridge AH, ,
Pain and health-related quality-of-life outcomes with darolutamide in metastatic hormone-sensitive prostate cancer (ARANOTE): secondary and exploratory analyses of a multicentre, randomised, placebo-controlled, phase 3 trial.
Morgans AK, Haresh KP, Jievaltas M, Olmos D, Shore ND, Vjaters E, Xing N, Mohamed AF, Littleton N, Srinivasan S, Verholen F, Saad F
The Oncology Care Model and Initiation of Systemic Therapy for Cancer.
Keating NL, Lam MB, Landrum MB, McWilliams JM, Wright AA, Brooks GA, Zubizarreta JR, Buzzee B, Landon BE
Clinical Trial Skepticism and Political Ideology Among US Adults and Cancer Survivors.
Chido-Amajuoyi OG, Onyeaka HK, Okafor CM, Keane EP, Taylor AO, Okpagu C, Amonoo HL
Sociodemographics and Attrition in Children With Osteosarcoma Enrolled in the AOST0331 Clinical Trial.
Zheng DJ, DelRocco N, Han R, Krailo M, Aziz-Bose R, Karvonen KA, Kelly CA, Newman H, Umaretiya PJ, Ilcisin L, Reed DR, Gorlick R, Janeway K, Bona K
Collecting Social Determinants of Health in a Children's Oncology Group Trial for High-Risk Neuroblastoma.
Jones E, Naranjo A, Winestone LE, Umaretiya PJ, Aziz-Bose R, Kelly CA, Newman H, Zheng DJ, Greengard E, Bagatell R, DuBois SG, Bona K
Perceived Value of Transfusion Access and Hospice Services Among Patients With Blood Cancers.
Raman HS, Cronin AM, Huntington SF, Uno H, Brennan C, Hurley SL, Tidswell A, Kaufman RM, Lanahan SM, Johnson KS, Tulsky JA, Abel GA, Odejide OO
